Shares of Bionano Genomics (NASDAQ:BNGO) rose 8.4% during market hours on Tuesday, only to fall roughly 10% after the market closed.
Investors bid up Bionano's stock price after the biotech said on Monday that its Saphyr optical genome mapping (OGM) system could detect structural variants that could make people more likely to get severe forms of COVID-19.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,